MedPage Today on MSN
Monoclonal Antibody Prevented Relapse in Adult-Onset Nephrotic Syndrome
Primary nephrotic syndrome in adults, including minimal-change nephrotic syndrome, has an incidence of roughly 0.2 to 0.8 per ...
News-Medical.Net on MSN
Rituximab shows remarkable success in adults with relapsing nephrotic syndrome
One monoclonal antibody, rituximab, can work wonders for the treatment of children with frequently relapsing nephrotic ...
Researchers from The University of Osaka have found that rituximab, a monoclonal antibody approved for the treatment of ...
Patients with nephrotic syndrome were far more likely than healthy controls to suffer end-stage kidney disease, particularly if they had focal segmental glomerulosclerosis or membranous nephropathy.
Nephrotic syndrome is a group of symptoms that indicate that the kidneys are not functioning as they should. Nephrotic syndrome can result from diseases that affect just the kidneys or the entire body ...
For very young children with nephrotic syndrome, longer initial treatment with prednisone didn't offer much benefit, a researcher reported. In a randomized controlled trial of 172 patients ages 1 to 4 ...
Idiopathic nephrotic syndrome is the most common disorder of glomerular function in pediatrics. [1] Approximately 40% of children diagnosed with idiopathic nephrotic syndrome will have a relapsing ...
A group led by the Department of Cell Biology at the Kidney Research Center, Niigata University revealed that elevated activity of cdc42 is a critical initiation event leading to proteinuria, and ...
The randomized, open-label INSHORE trial (ClinicalTrials.gov Identifier: NCT05627557) evaluated the safety and efficacy of obinutuzumab in children and young adults in clinical remission aged 2 to 25 ...
One monoclonal antibody, rituximab, can work wonders for the treatment of children with frequently relapsing nephrotic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results